Biotechnology A new DNA test will look for 190 diseases in your newborn’s genetic code But not all parents may want to know the results. by Emily Mullin 2018-02-07T07:00:00-05:00
Biotechnology A search for insomnia genes involving 1.3 million people is the largest genetic study ever The quest to understand common diseases takes on unprecedented scope. by Antonio Regalado 2018-02-02T00:00:00-05:00
Biotechnology As Consumer DNA Testing Grows, Two States Resist Maryland and New York still restrict who can order genetic tests and how companies can market them. by Emily Mullin 2017-09-28T13:31:00-04:00
Rewriting Life Promising New Cancer Drugs Won’t Go Far Unless Everyone Gets Genetic Testing Loxo Oncology is developing a so-called “tumor agnostic” drug that requires expensive genetic testing often not covered by insurance. by Emily Mullin 2017-06-06T00:00:00-04:00
Business Impact Taking Genomic Data Global Startups focused on Asia are among those aiming to bring precision medicine to far more people. by Elizabeth Woyke 2016-07-25T00:00:00-04:00
Rewriting Life Should We Sequence the DNA of Every Cancer Patient? To match cancer patients with drugs, one company plans to offer free genetic tests. by Antonio Regalado 2016-06-14T17:30:00-04:00
Rewriting Life 2013: The Best Biomedicine Stories of the Year A push for new brain-mapping technology and a ban on some gene patents showcase ongoing advances in biomedical technology. by Susan Young Rojahn 2013-12-23T00:00:00-05:00
Rewriting Life Why We Have a Right to Consumer Genetics It’s hard to get straightforward health guidance from personal genome tests, which are banned in some places. But one way to make them more meaningful is to let more people buy them. by Susan Young Rojahn 2013-01-02T13:00:00-05:00
Rewriting Life Personal Genetics Company Seeks Regulatory Approval The FDA is unlikely to rule out personal genetics tests, but it may require that physicians get more involved. by Susan Young Rojahn 2012-08-03T14:49:00-04:00
Rewriting Life Analyzing the Unborn Genome Mapping the genome of a fetus from its mother’s blood could mean less risky screening for prenatal diseases. by Emily Singer 2010-12-09T00:00:00-05:00